Inventor · disambiguated record
Fei Han
Also filed as: HAN FEI
4 granted patents·3 pending applications·2 citations·filing 2020–2024
60Inventor score
Files withBOEHRINGER INGELHEIM INT7
Top patents by PatentIndex Score
7 records- 0182US11661458B2Anti-NRP1A antibodies and their uses for treating eye or ocular diseasesBOEHRINGER INGELHEIM INT·Filed 2020·Granted May 30, 2023·1 cites·35 claims
- 0279US11267880B2Anti-Sema3A antibodies and their uses for treating eye or ocular diseasesBOEHRINGER INGELHEIM INT·Filed 2020·Granted Mar 8, 2022·1 cites·26 claims
- 0375US2024336674A1Anti-sema3a antibodies and their uses for treating eye or ocular diseasesBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0474US2025051460A1Bispecific anti-vegf and anti-trkb binding molecules for the treatment of eye diseasesBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0567US2022144929A1Anti-sema3a antibodies and their uses for treating eye or ocular diseasesBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 0664US12110335B2Bispecific anti-VEGF and anti-TrkB binding molecules for the treatment of eye diseasesBOEHRINGER INGELHEIM INT·Filed 2021·Granted Oct 8, 2024·0 cites·15 claims
- 0754US12312405B2Anti-PD-1 antibodiesBOEHRINGER INGELHEIM INT·Filed 2021·Granted May 27, 2025·0 cites·86 claims
Join the waitlist — get patent alerts
Get an alert when Fei Han files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →